S Ozawa, A Mirelman, ML Stack, DG Walker… - Vaccine, 2012 - Elsevier
BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly increased over the past decade. Immunization is one of these preventive interventions, with …
M Fesenfeld, R Hutubessy, M Jit - Vaccine, 2013 - Elsevier
Abstract The World Health Organization recommends establishing that human papillomavirus vaccination is cost-effective before vaccine introduction. We searched …
Background WHO recommends isoniazid preventive therapy (IPT) for young children in close contact with an infectious tuberculosis (TB) case. No models have examined the cost …
M Ngoma, P Autier - Ecancermedicalscience, 2019 - ncbi.nlm.nih.gov
Cervical cancer is the fourth most common cancer in women, and the seventh overall, with an estimated 528,000 new cases and 266,000 deaths in 2012 [1]. Almost nine out of ten …
Introduction: Human papillomavirus (HPV) is one of the world's most common sexually transmitted infections, and has been associated with a number of cervical and non-cervical …
I Moodley, N Tathiah, V Mubaiwa, L Denny - South African Medical Journal, 2013 - ajol.info
High uptake of Gardasil vaccine among 9 - 12-year- old schoolgirls participating in an HPV vaccination demonstration project in Page 1 RESEARCH 318 May 2013, Vol. 103, No. 5 …
G Van Kriekinge, X Castellsagué, D Cibula… - Vaccine, 2014 - Elsevier
Background Human papillomavirus (HPV) vaccination offers potential for primary prevention of HPV-related pre-cancers and cancers as demonstrated in clinical trials. Mathematical …
Cervical cancer, a largely preventable disease, is one of the most common cancers found in women living in low-and middle-income countries (LMICs). A striking reduction in the …
Background Seasonal influenza imposes a significant health and economic burden in South Africa, particularly in populations vulnerable to severe consequences of influenza. This …